CorMatrix
CorMatrix (legal entity Corvivo, Inc.) is a privately held medical device company that develops and sells biomaterial-based cardiovascular and soft tissue repair patches to hospitals and surgical centers performing cardiovascular reconstruction procedures.
- Company typePrivate
- Founded2001
- HeadquartersRoswell, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What CorMatrix does
CorMatrix, legally operating as Corvivo, Inc. and doing business as "CorMatrix Cardiovascular," is a privately held medical device company founded in 2001 and headquartered in Roswell, Georgia. The company develops and sells biomaterial-based devices — primarily cardiovascular and soft tissue repair patches — designed to harness the body's natural ability to regenerate damaged cardiac tissue. Its core technology centers on extracellular matrix biomaterials used in cardiovascular reconstruction procedures, and the company self-positions as a "World Leader in Cardiovascular Regeneration."
The company's commercial model is a direct hardware-sales business targeting hospitals and medical institutions performing cardiovascular surgery. It reaches healthcare providers through direct sales channels supported by phone (678-566-2628) and email ([email protected]) customer service infrastructure, and uses email/newsletter registration for ongoing customer engagement. Hospitals represent the dominant end-user channel in its addressable market (44.1%), and the broader cardiovascular and soft tissue repair patches market is sized at approximately $5.2 billion in 2025, projected to reach $9.1 billion by 2032 at an 8.2% CAGR, with North America holding 38.7% regional share.
CorMatrix operates with a lean team of 51-100 employees and is led by founder-CEO and Chairman David B. Camp, alongside a small executive team covering strategy, finance, medical affairs, and sales/marketing. The company has historically funded operations through capital markets — raising approximately $55.9 million across four disclosed rounds in 2013-2015 — though no further funding activity has been recorded in over a decade, and no revenue figures, customer counts, regulatory milestones, patents, or partnerships are publicly disclosed.
CorMatrix firmographics
Firmographics- Name
- CorMatrix
- Legal name
- Corvivo, Inc.
- Website
- https://cormatrix.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- CorMatrix (legal entity Corvivo, Inc.) is a privately held medical device company that develops and sells biomaterial-based cardiovascular and soft tissue repair patches to hospitals and surgical centers performing cardiovascular reconstruction procedures.
- Ownership category
- akta.pro rank
Where CorMatrix is headquartered
LocationHeadquarters
- HQ city
- Roswell
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
CorMatrix business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Cardiovascular Medical Device Sales: Revenue generated from the sale of cardiovascular and soft tissue repair patches to healthcare providers, primarily hospitals performing cardiovascular reconstruction procedures.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
CorMatrix product offering
Product offeringCore offering
CorMatrix (operating as Corvivo, Inc.) develops and sells biomaterial medical devices, principally cardiovascular and soft tissue repair patches, that leverage the body's natural ability to regenerate damaged heart and soft tissues. Its core offering targets cardiac surgeons and hospitals performing cardiovascular reconstruction, extremity vascular injury repair, and other soft tissue repair procedures.
Product overview
CorMatrix (operating as Corvivo, Inc.) is a medical technology company specializing in cardiovascular regeneration. The company appears to offer a core cardiovascular repair product line, though specific product names and detailed descriptions are limited in the available source data. Contact and news registration services are available through their website.
Differentiator
Problem solved
Functional benefit
Products and services
- CorMatrix Cardiovascular Repair Patches Biomaterial cardiovascular and soft tissue repair patches designed to harness the body's ability to regenerate damaged heart and soft tissues; sold to cardiac surgeons and hospitals for cardiovascular reconstruction, extremity vascular injury repair, and soft tissue repair procedures.
Companies that use CorMatrix
Customer profileSegments1 record
Ideal customer profiles1 record
CorMatrix technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
CorMatrix partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Expansion highlights4 records
CorMatrix competitors and assessment
Company assessmentBroad incumbents
- Edwards Lifesciences: Edwards Lifesciences is a global leader in structural heart and critical care. It competes with CorMatrix in cardiovascular surgery through valve repair and cardiac surgery adjunct products, making it a broad incumbent with overlapping cardiac OR customers.
- Abbott (Cardiovascular): Abbott's cardiovascular division sells a broad portfolio across structural heart, cardiac surgery, and vascular repair. It overlaps with CorMatrix's hospital customer base and competes in surgical patch and graft adjacencies as part of a much larger portfolio.
- Medtronic: Medtronic is a global cardiovascular incumbent with cardiac surgery and vascular repair offerings. It competes with CorMatrix for hospital cardiac surgery budgets and serves as a benchmark for what scaled incumbents can offer bundling surgical patches with valves and other devices.
- Getinge (Maquet): Getinge's Maquet brand sells cardiac surgery products including patches and grafts used in operating rooms. It overlaps with CorMatrix's hospital channel and competes in cardiac reconstruction consumables as part of a broader surgical portfolio.
Direct peers
- Artivion (formerly CryoLife): Artivion specializes in cardiac and vascular surgery, including tissue patches and biomaterials for cardiac repair—the most direct competitor to CorMatrix's cardiovascular regeneration patch portfolio in US hospital cardiac surgery.
- W. L. Gore & Associates (Gore Medical): Gore Medical manufactures GORE-TEX and other surgical patches widely used in cardiac and vascular reconstruction. It is a direct peer given its flagship synthetic surgical patch lines compete head-to-head with CorMatrix in the same cardiac OR procedures.
- Terumo (Terumo Aortic / Vascutek): Terumo's aortic and vascular division (including the former Vascutek and Bolton Medical lines) sells surgical grafts and patches used in cardiovascular reconstruction. It directly competes with CorMatrix in cardiac and vascular patch applications.
- LeMaitre Vascular: LeMaitre Vascular specializes in vascular and cardiac surgery disposables including patches and grafts. It is a direct peer serving the same vascular and cardiovascular reconstruction surgical procedures as CorMatrix.
Emerging players
- Anteris Technologies: Anteris is an emerging structural heart company developing regenerative tissue-engineered cardiovascular products including biomaterial scaffolds. It is an emerging peer with overlapping cardiovascular regeneration and biomaterial technology focus.
- Admedus (Anteris subsidiary, formerly Admedus Solutions): Admedus developed CardioCel and other regenerative tissue patches for cardiac and vascular repair, making it an emerging biomaterial patch peer with overlapping cardiovascular regeneration focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
CorMatrix social profiles
Digital presenceCorMatrix financial estimates
Financial estimateRevenue estimate
Valuation estimate
CorMatrix leadership team
Management profileNumber of profiles
Profiles5 records
CorMatrix funding detail
Funding detailFunding overview
Funding rounds4 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CorMatrix M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CorMatrix
What does CorMatrix do?
CorMatrix (operating as Corvivo, Inc.) develops and sells biomaterial medical devices, principally cardiovascular and soft tissue repair patches, that leverage the body's natural ability to regenerate damaged heart and soft tissues. Its core offering targets cardiac surgeons and hospitals performing cardiovascular reconstruction, extremity vascular injury repair, and other soft tissue repair procedures.
When was CorMatrix founded?
CorMatrix was founded in 2001. It employs 51 to 100 people.
Where is CorMatrix based?
CorMatrix is headquartered in Roswell, United States, in the North America region.
How does CorMatrix make money?
One revenue line is on record: cardiovascular Medical Device Sales.
Who are CorMatrix's main competitors?
Broad incumbents on record are Edwards Lifesciences, Abbott (Cardiovascular), Medtronic and Getinge (Maquet). Direct peers are Artivion (formerly CryoLife), W. L. Gore & Associates (Gore Medical), Terumo (Terumo Aortic / Vascutek) and LeMaitre Vascular. Emerging players are Anteris Technologies and Admedus (Anteris subsidiary, formerly Admedus Solutions).
Does CorMatrix have an API?
No public API is recorded for CorMatrix.